Track the LIFECORE BIOMEDICAL, INC. \DE\ share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €140.1m. The latest transaction was filed on 5 June 2026 (Attribution). Among the most active insiders: Kiper Christopher S. All data is free.
74
Insider Decl.
n/a
Thresholds
€8m
4 ops.
Buy Volume
€8m
6 ops.
Sell Volume
30Σ signal
Buys €8m€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,796 of 29,062 companies
19.4
score / 100
Value
14
Quality
25
FCF yld-9.2%
Earn yld-22%
EV/EBITDA·
ROE·
Gross mgn31%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
17,000 shares@ US$5.7442.7% of flowCommon StockSEC:0001628280-25-000943:0
Canonical exit: 8 Apr 2025 (T+90)
25 of 74 declarations
About LIFECORE BIOMEDICAL, INC. \DE\
LIFECORE BIOMEDICAL, INC. is a company focused on the development and manufacturing of biomedical products. It is listed on NASDAQ under the symbol XNAS.